EXHIBIT 23.2

                         CONSENT OF INDEPENDENT AUDITORS


We consent to the reference to our firm under the caption "Experts" in Amendment
No. 3 to the Registration Statement (Form S-3 No. 333-66350) and related
Prospectus of Peregrine Pharmaceuticals, Inc. for the registration of 11,049,991
shares of its common stock and to the incorporation by reference therein of our
report dated June 29, 2001, except for Notes 1 and 14, as to which the date is
July 15, 2001, with respect to the consolidated financial statements and
schedule of Peregrine Pharmaceuticals, Inc. included in its Annual Report (Form
10-K) for the year ended April 30, 2001, filed with the Securities and Exchange
Commission.


                                                           /s/ ERNST & YOUNG LLP



Orange County, California
November 2, 2001